主要成果与奖励 |
代表性研究成果： 1.Peijie Lu, Pei Zhang, Yuchun Liu, Na Jing, Yanan Guo, Pengshuai Wang, Linlin Su, Qi Guo,Qiang Ma(*), Yuming Xu(*), Shoutao Zhang(*). Gene Repair of iPSC Line with GARS (G294R) Mutation of CMT2D Disease by CRISPR/Cas9[J].Current Medical Science, 2023 Apr;43(2):261-267. 2.Yuchun Liu, Yao Sun, Shaoming Han, Yanan Guo, Qingnan Tian,Qiang Ma(*), Shoutao Zhang(*). CHIP promotes the activation of NF-κB signaling through enhancing the K63-linked ubiquitination of TAK1[J].Cell Death Discov., 2021 Sep 17;7(1):246. 3.Kemin Liu, Mingyu Xie, Xiaomei Lu, Hui Yu, Hui Wang, Yunjian Xu, Qingqing Yang, Yongping Lin(*),Qiang Ma(*). Mutations within the major hydrophilic region (MHR) of Hepatitis B virus from individuals with simultaneous HBsAg and anti-HBs in Guangzhou, Southern China[J],J Med Virol., 2018 Aug;90(8):1337-1342. 4.Qiang Ma(#), Xingui Tian(#), Zaixue Jiang, Junfeng Huang, Qian Liu, Xiaomei Lu, Qingming Luo(*), Rong Zhou(*). Neutralizing epitopes mapping of human adenovirus type 14 hexon [J], Vaccine, 2015 Nov 27, 33(48):6659-65. 5. Xingui Tian(#),Qiang Ma(#), Zaixue Jiang, Junfeng Huang, Qian Liu, Xiaomei Lu, Qingming Luo(*), Rong Zhou(*). Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein [J],Viruses, 2015 Oct 27, 7(10):5632-42. 主持的科研项目： 1. 横向课题，20230482A，乙肝病毒免疫逃逸突变检测试剂盒的研发，2023/7-2025/7，20万、主持； 2. 河南省自然科学基金，202300410381，表面抗原突变在慢性乙肝表面抗原抗体双阳发生中的作用机制研究，2020/1-2021/12，5万、主持； 3. 广州市博士后科研项目启动基金，2013010，基于人3型腺病毒衣壳展示的病毒性疾病疫苗候选株研究、2013/08-2015/08，15万，主持。 |
